Preimplantation Genetic Testing Market 2020 Global Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2025

Developing knowledge about genetic systems for identification of chromosomal variations from the norm and fetus screening for effective IVF holds development prospects for this vertical over the estimate time frame. Early discovery of the chromosomal maladies, which holds potential for lowering the quantity of individuals experiencing intrinsic ailments, PGD can be performed for screening of a scope of restorative conditions, for example, Down’s syndrome, inheritable illnesses and qualities of other physiological anomaly. Expanding tolerant awareness about PGD system and rising predominance of hereditary issue among newborn children has prompted the ascent sought after for PGD alongside IVF methodology. The mix of PGD and IVF has enhanced the rate of fruitful pregnancy because of decreased odds of passing the undesired hereditary material in the developing life. Thus decreases the quantity of offspring’s conceived with acquired chromosomal variations from the norm. This can be credited to the expanded interest for Preimplantation genetic testing (PGT) administrations.

The scope of the report includes a detailed study of global and regional markets on Global Preimplantation Genetic Testing Market with the reasons given for variations in the growth of the industry in certain regions.

You Can Browse Full Report @:

The Global Preimplantation Genetic Testing Market is expected to exceed more than US$ 650 Million by 2024 at a CAGR of 10% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Cooper Surgical, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China) Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Preimplantation Genetic Testing Market is segmented on the lines of its technology, product & service, procedure type, application, end user and regional. Based on technology segmentation it covers next generation sequencing (NGS), polymerase chain reaction (PCR), fluorescent in-situ hybridization (FISH), comparative genomic hybridization (CGH), single nucleotide polymorphism (SNP). Based on product & service segmentation it covers reagents & consumables, instruments, software & services. Based on procedure type segmentation it covers preimplantation genetic screening, preimplantation genetic diagnosis. Based on application segmentation it covers aneuploidy, structural chromosomal abnormalities, and single gene disorders, x-linked disorders, hla typing, gender identification. Based on end user segmentation it covers maternity centers & fertility clinics, hospitals, diagnostic labs, and service providers, research laboratories & academic institutes. The Global Preimplantation Genetic Testing Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Global Preimplantation Genetic Testing Market has been segmented as below:

The Global Preimplantation Genetic Testing Market is Segmented on the lines of Technology Analysis, Product & Service Analysis, Procedure Type Analysis, Application Analysis, End User Analysis and Regional Analysis. By Technology Analysis this market is segmented on the basis of Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-situ Hybridization (FISH), Comparative Genomic Hybridization (CGH) and Single Nucleotide Polymorphism (SNP). By Product & Service Analysis this market is segmented on the basis of Reagents & Consumables, Instruments and Software & Services. By Procedure Type Analysis this market is segmented on the basis of Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis.

By Application Analysis this market is segmented on the basis of Aneuploidy, Structural Chromosomal Abnormalities its covers Translocations, Deletions, Duplications & Inversions. Single Gene Disorders, X-linked Disorders, HLA Typing and Gender Identification. By End User Analysis this market is segmented on the basis of Maternity Centers & Fertility Clinics sector, Hospitals, Diagnostic Labs, and Service Providers sector and Research Laboratories & Academic Institutes sector. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Preimplantation Genetic Testing Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Preimplantation Genetic Testing Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global Preimplantation Genetic Testing Market are as follows:

  • Decreasing fertility rates worldwide
  • Growing public-private savings in the field of preimplantation genetic testing
  • Increasing number of fertility clinics worldwide
  • New development technological advancements in the field of genetic analysis
  • Highly threat of chromosomal abnormalities with advancing maternal age

The restraining factors of Global Preimplantation Genetic Testing Market are as follows:

  • Adverse government regulations
  • Expensive practical associated with preimplantation genetic testing
  • Procedural drawbacks of Preimplantation Genetic Testing With Advancing Age
  • Socio ethical interests Regarding Preimplantation Genetic examination

Request Sample Report:

Table of Contents

1 Introduction

1.5.1    MARKET SIZE

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Preimplantation Genetic Testing Market: Overview

6 Industry Insights

7 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type

8 Preimplantation Genetic Diagnosis and Screening Market, By Technology

9 Preimplantation Genetic Diagnosis and Screening Market, By Product and Service

10 Preimplantation Genetic Diagnosis and Screening Market, By Application

11 Preimplantation Genetic Diagnosis and Screening Market, By End User

12 Preimplantation Genetic Diagnosis and Screening Market, By Region

13 Preimplantation Genetic Testing Market: Competitive Landscape

14 Company Profiles

14.1 Top Product Manufacturers

14.1.1 Illumina, Inc.

14.1.2 Thermo Fisher Scientific Inc.

14.1.3 Agilent Technologies, Inc.

14.1.4 Perkinelmer, Inc.

14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)

14.1.6 ABBott Laboratories

14.1.7 Natera, Inc.

14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)

14.1.9 Oxford Gene Technology

14.1.10 Yikon Genomics

14.1.11 Scigene

14.2 Top Service Provider Companies

14.2.1 Beijing Genomics Institute

14.2.2 Good Start Genetics, Inc.

14.2.3 Invicta Genetics

14.2.4 Combimatrix Corporation

14.2.5 Genea Limited

14.2.6 Progenesis

Other Related Market Research Reports:

Plasma Fractionation Market to hit more than US$ 26 Billion By 2022

Planting Equipment Market is Expected to Grow US$ 20 Billion By 2022

Phosphate Esters Market Growth Factors Analysis, Product Overview and Share Forecasted to 2022

Media Contact

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States